Related Experiment Video
Updated: Sep 15, 2026

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
Micron-scale lactoferrin proteinosomes potentiate immune activation and chemo-immunotherapy in breast cancer
Miaomiao Xu1, Shenghao Hu2, Shuqing Gan2
1State Key Laboratory of Flexible Electronics (LoFE) & Jiangsu Key Laboratory of Smart Biomaterials and Theranostic Technology, Institute of Advanced Materials (IAM), Jiangsu National Synergetic Innovation Center for Advanced Materials (SICAM), Nanjing University of Posts and Telecommunications, Nanjing, 210023, China; State Key Laboratory of Molecular Engineering of Polymers, Department of Macromolecular Science, Fudan University, Shanghai, 200438, China.
Abstract:
Efficient uptake by antigen-presenting cells (APCs) is critical for the immunostimulatory performance of protein-based adjuvants, yet soluble proteins often suffer from poor cellular internalization and transient immune activation. Here, we report a hierarchical micron-scale assembly strategy to construct lactoferrin proteinosomes (LPs) via interfacial self-assembly. The resulting spherical LPs, with an average diameter of ∼2 μm, exhibit robust structural stability while retaining the native secondary structure of lactoferrin. Compared with monomeric lactoferrin, LPs markedly enhance internalization by macrophages and dendritic cells (DCs). LPs promote pro-inflammatory macrophage activation, evidenced by upregulated CD80, CD86 and MHC-II expression and elevated secretion of IL-1β, TNF-α, IL-6, and nitric oxide. Transcriptomic profiling further revealed an inflammatory gene-expression signature associated with multiple innate immune signaling pathways in LP-treated macrophages. Moreover, LPs promote DC phenotypic maturation in vitro and enhance DC activation in lymph nodes in vivo, accompanied by a favorable biosafety profile and elevated systemic levels of immunostimulatory cytokines. In a 4T1 breast tumor model, combined administration of LPs and doxorubicin significantly improves therapeutic outcomes by remodeling the tumor immune microenvironment, as indicated by increased infiltration of macrophages, DCs, and T cells. Collectively, this work demonstrates the potential of hierarchical micron-scale assembly for enhancing the immunoadjuvant activity of proteins in combined cancer therapy.
Related Concept Videos
The Tumor Microenvironment
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...